Chemical skin irritation testing standards establish the scientific frameworks and internationally recognized protocols used to evaluate whether substances cause reversible damage to human skin. This article explains the key standards—including OECD, ISO, EN, and GB test guidelines—covering classification criteria, testing methodologies, sample requirements, and regulatory applications across industrial chemicals, cosmetics, medical devices, and consumer products. Whether you are preparing a REACH registration, a GHS classification dossier, or a product safety file, understanding these standards is essential for compliant global market access.
Technical Overview
Skin irritation testing is a core component of chemical hazard assessment designed to determine whether a substance produces reversible damage to the skin following exposure. Under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), skin irritation is distinguished from skin corrosion: corrosion refers to the production of irreversible tissue damage (necrosis) extending into the dermis, while irritation involves reversible inflammatory effects such as erythema and edema that resolve within a defined observation period.
The regulatory landscape for skin irritation testing has shifted dramatically over the past two decades from traditional animal-based methods toward validated in vitro alternatives. The main standards and frameworks governing this field include:
- OECD Test Guideline 439 – In Vitro Skin Irritation: Reconstructed Human Epidermis (RhE) Test Method, the primary replacement for animal testing for skin irritation classification.
- OECD Test Guideline 404 – Acute Dermal Irritation/Corrosion, the traditional in vivo rabbit method, now applied only as a last resort within an integrated testing strategy.
- OECD Test Guidelines 430, 431, and 435 – In vitro methods for skin corrosion screening (transcutaneous electrical resistance, human skin models, and membrane barrier tests).
- ISO 10993-10 – Tests for irritation and skin sensitization within the biological evaluation of medical devices.
- GB/T 21604 – Chinese national standard for the acute dermal irritation and corrosion test of chemicals, aligned with OECD principles.
- GB/T 16886.10 – Chinese adoption of ISO 10993-10 for medical device irritation testing.
- EU CLP Regulation (EC) No 1272/2008 and REACH Regulation (EC) No 1907/2006 – Legal frameworks in the European Union defining classification criteria and data requirements.
Under GHS, chemicals are classified as Skin Corrosion Category 1 (with sub-categories 1A, 1B, and 1C based on the time required to produce corrosion) or Skin Irritation Category 2 (reversible damage observed within 14 days). Some jurisdictions historically recognized a Category 3 (mild irritant), though this has largely been integrated into Category 2 in current implementations.
Accredited third-party laboratories performing these tests must operate under Good Laboratory Practice (GLP) principles, particularly when data are submitted for regulatory notification of new chemical substances or biocidal products.
Testing Samples
Pure and Technical-Grade Chemical Substances
Single-ingredient chemicals, intermediates, and technical-grade materials intended for industrial registration (for example, under REACH or China's new chemical substance notification scheme) are tested to determine their intrinsic skin irritation hazard. Solid, liquid, and viscous materials are all acceptable, though solids may need to be moistened with water or a suitable vehicle to ensure adequate skin contact in certain test systems.
Mixtures and Formulated Products
Multi-component formulations such as detergents, cleaning agents, paints, adhesives, lubricants, and agrochemical formulations are tested as sold. Where testing the complete formulation is not feasible, bridging principles or calculation methods based on component classification may be applied in accordance with GHS mixture rules.
Cosmetic Products and Ingredients
Finished cosmetics and raw materials destined for the EU, and increasingly other markets, must be evaluated using non-animal methods in line with the animal testing bans established under EU Cosmetics Regulation (EC) No 1223/2009. RhE-based in vitro methods are the standard approach for these submissions.
Medical Device Extracts
For medical devices contacting intact or breached skin, irritancy is evaluated according to ISO 10993-10 using polar and non-polar extracts prepared under ISO 10993-12 conditions. The extract is typically applied intracutaneously in animal models or topically using advanced in vitro models, depending on the device category and regional acceptance.
Sample Quantity and Packaging Requirements
- Typical sample volume: 20–100 g or 20–100 mL depending on the method selected and the number of replicates.
- Samples should be representative of the commercial batch and accompanied by composition information, physical/chemical data, and safety handling instructions.
- Stability, storage conditions, and expiry information should be provided to ensure test validity.
Testing Items
Depending on regulatory objectives and available data, the following testing items are commonly commissioned:
- In vitro skin irritation (RhE method) – Classification of a substance as irritant (GHS Category 2) or non-classified based on tissue viability.
- In vitro skin corrosion – Discrimination of corrosive from non-corrosive materials and, in some protocols, sub-categorization into GHS 1A/1B/1C.
- Acute dermal irritation/corrosion (in vivo) – Conducted only when in vitro data are inconclusive or not applicable, following the tiered strategy in OECD TG 404.
- Intracutaneous reactivity test – For medical device extracts per ISO 10993-10 and GB/T 16886.10.
- Skin sensitization screening – Often requested alongside irritation to complete the local toxicity profile (OECD TG 442 series, e.g., DPRA, KeratinoSens, and human cell line activation test methods).
- Labeling and classification assessment – Derivation of GHS/CLP hazard statements, pictograms, and precautionary statements from the resulting data.
Testing Methods
Reconstructed Human Epidermis (RhE) Test – OECD TG 439
The RhE method is the internationally accepted standard for skin irritation testing. Commercially available three-dimensional human skin models consist of a functional epidermis with a stratum corneum. The test chemical is applied topically to the tissue surface for a defined exposure period (typically 42 minutes, followed by a 42-hour post-incubation). Tissue viability is then quantified using the MTT reduction assay, which measures metabolic activity of viable cells.
- Mean tissue viability ≤ 50% relative to the negative control indicates the chemical is classified as a skin irritant (GHS Category 2, EU CLP Category 2).
- Mean tissue viability > 50% indicates the chemical is not classified for skin irritation under GHS/CLP.
- The method applies to solids, liquids, and semi-solids, subject to compatibility with the MTT endpoint (colorants and MTT-reducing chemicals require specific correction procedures).
Skin Corrosion Tests – OECD TG 431, 430, and 435
Before irritation testing, available corrosion data or predictive tools (pH, acid/alkali reserve, structure–activity relationships) are assessed. Where experimental data are needed, validated methods include the human skin model test (OECD TG 431), the transcutaneous electrical resistance test using rat skin discs (OECD TG 430), and the in vitro membrane barrier test based on Corrositex-type technology (OECD TG 435). These tests form the first tiers of the integrated testing strategy defined in OECD TG 404.
In Vivo Rabbit Test – OECD TG 404 and GB/T 21604
The traditional Draize-type test involves applying the test substance to the clipped skin of albino rabbits for up to four hours and scoring erythema and edema at defined intervals over 14 days using a standardized grading scale. Current regulations require that this method be used only as a last resort after exhaustively considering existing data, QSAR predictions, pH extremes, and validated in vitro results. Animal welfare principles (the 3Rs – replacement, reduction, refinement) are embedded in all modern testing strategies.
Medical Device Irritation – ISO 10993-10 / GB/T 16886.10
Device extracts are evaluated for irritancy, most commonly via the intracutaneous reactivity test in rabbits, in which extracts are injected intradermally and sites are scored for erythema and edema. Topical application procedures and emerging in vitro alternatives are gaining regulatory acceptance, particularly for devices contacting intact skin.
Quality and Data Integrity
Testing should be performed by accredited third-party laboratories under ISO/IEC 17025 quality systems and, for regulatory submissions, in GLP-compliant facilities. Test reports must include full method details, controls, raw viability or grading data, classification conclusions, and GLP or quality statements as required by the receiving authority.
Applications
Skin irritation test data generated according to these standards serve multiple regulatory and commercial purposes:
- Chemical registration and notification – REACH registrations in the EU, China's new chemical substance environmental registration, K-REACH in Korea, and similar schemes worldwide require skin irritation/corrosion information for hazard classification.
- GHS labeling and safety data sheets – Classification results directly determine hazard pictograms (corrosion symbol), signal words (Danger or Warning), and precautionary statements on labels and SDS Section 2.
- Cosmetics safety dossiers – Non-animal irritation data support product information files and safety assessments required under cosmetics regulations in the EU, China, and ASEAN markets.
- Medical device biocompatibility – ISO 10993-10 irritation data form part of the biological evaluation required for regulatory clearance of skin-contacting and invasive devices.
- Transport of dangerous goods – Corrosivity data support classification under UN Model Regulations for air, sea, and land transport.
- Occupational health and product stewardship – Employers and formulators use irritation data to define safe handling procedures, personal protective equipment requirements, and workplace exposure controls.
FAQ
What is the difference between skin irritation and skin corrosion?
Skin corrosion causes irreversible damage to the skin, visible as necrosis extending through the epidermis into the dermis, with scarring expected upon healing. Skin irritation causes reversible damage, typically observed as redness (erythema) and swelling (edema) that fully resolve within 14 days after exposure.
Why are in vitro methods now preferred over animal testing?
Validated RhE methods have demonstrated equivalent or superior predictivity for human responses compared with the rabbit test, while satisfying animal welfare legislation such as the EU Cosmetics Regulation testing ban and the 3Rs principles. Regulatory authorities in the EU, China, and OECD member countries accept OECD TG 439 data for classification purposes.
What does a positive result in the RhE test mean?
A mean tissue viability of 50% or less after chemical exposure indicates classification as a skin irritant (GHS/CLP Category 2), triggering corresponding hazard labeling requirements. Results above 50% support no classification for skin irritation, provided the substance is not otherwise corrosive.
How much sample is required and how long does testing take?
For the in vitro RhE test, typically 20–50 g or mL of sample is sufficient, and the experimental phase is usually completed within two to four weeks, including repeat runs if required. In vivo studies and medical device extract tests may require additional scheduling time and sample quantities.
Which standard should I choose for my product?
The choice depends on the product type and target market: OECD TG 439 for industrial chemicals and cosmetics under GHS-based classification; OECD TG 404 (last resort) or corrosion guidelines as part of a tiered strategy; and ISO 10993-10 / GB/T 16886.10 for medical devices. Consulting an accredited third-party laboratory at the design stage ensures the correct test selection and avoids redundant testing.
Is Chinese GB testing accepted internationally?
GB/T 21604 is technically aligned with OECD TG 404, and GB/T 16886.10 is an adoption of ISO 10993-10, ensuring mutual compatibility of the underlying science. Acceptance of a specific report ultimately depends on the receiving authority and whether the laboratory holds the required GLP status or accreditation, so confirm submission requirements with the destination regulator in advance.
